Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (321-330 of 565) with videos related to

Pageof 57
Sort By:
The American Journal of Psychiatry|February 19, 2008
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescentsGraham J Emslie, Beth D Kennard, Taryn L Mayes, et al.
Journal of Proteome Research|February 10, 2012
Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case studySheng Pan, Ru Chen, Randall E Brand, et al.
Psychiatric Services (Washington, D.C.)|August 10, 2005
Characteristics of insured and noninsured outpatients with depression in STAR(*)DIra M Lesser, Andrew F Leuchter, Madhukar H Trivedi, et al.
Medical Care|December 1, 2007
Ethnicity/race and outcome in the treatment of depression: results from STAR*DIra M Lesser, Daniel B Castro, Bradley N Gaynes, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|June 30, 2007
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysisWilliam R Yates, Jeff Mitchell, A John Rush, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
The Journal of ECT|September 7, 2007
DSM melancholic features are unreliable predictors of ECT response: a CORE publicationMax Fink, A John Rush, Rebecca Knapp, et al.
Journal of Affective Disorders|April 5, 2022
Genomics-based identification of a potential causal role for acylcarnitine metabolism in depressionYuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, et al.
General Hospital Psychiatry|February 2, 2010
The impact of diabetes on depression treatment outcomesCharlene Bryan, Thomas Songer, Maria Mori Brooks, et al.
The American Journal of Psychiatry|March 28, 2015
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D TrialBruce A Arnow, Christine Blasey, Leanne M Williams, et al.
Pageof 57

Showing results (321-330 of 565) with videos related to

Sort By:
Pageof 57
The American Journal of Psychiatry|February 19, 2008
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescentsGraham J Emslie, Beth D Kennard, Taryn L Mayes, et al.
Journal of Proteome Research|February 10, 2012
Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case studySheng Pan, Ru Chen, Randall E Brand, et al.
Psychiatric Services (Washington, D.C.)|August 10, 2005
Characteristics of insured and noninsured outpatients with depression in STAR(*)DIra M Lesser, Andrew F Leuchter, Madhukar H Trivedi, et al.
Medical Care|December 1, 2007
Ethnicity/race and outcome in the treatment of depression: results from STAR*DIra M Lesser, Daniel B Castro, Bradley N Gaynes, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|June 30, 2007
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysisWilliam R Yates, Jeff Mitchell, A John Rush, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
The Journal of ECT|September 7, 2007
DSM melancholic features are unreliable predictors of ECT response: a CORE publicationMax Fink, A John Rush, Rebecca Knapp, et al.
Journal of Affective Disorders|April 5, 2022
Genomics-based identification of a potential causal role for acylcarnitine metabolism in depressionYuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, et al.
General Hospital Psychiatry|February 2, 2010
The impact of diabetes on depression treatment outcomesCharlene Bryan, Thomas Songer, Maria Mori Brooks, et al.
The American Journal of Psychiatry|March 28, 2015
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D TrialBruce A Arnow, Christine Blasey, Leanne M Williams, et al.
Pageof 57